• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of nutrition-induced epigenetic changes in hepatocytes and their application to the regulation of hepatocellular carcinoma development and progression.

Research Project

Project/Area Number 21K07904
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 53010:Gastroenterology-related
Research InstitutionKumamoto University (2023)
Nagasaki International University (2021)

Principal Investigator

SASAKI Yutaka  熊本大学, 大学院生命科学研究部(医), 名誉教授 (70235282)

Co-Investigator(Kenkyū-buntansha) 長岡 克弥  熊本大学, 病院, 助教 (00759524)
渡邊 丈久  熊本大学, 大学院生命科学研究部(医), 助教 (20634843)
吉村 亮二  長崎国際大学, 公私立大学の部局等, 講師 (20782569)
山添 太士  国立研究開発法人国立国際医療研究センター, 肝炎・免疫研究センター, 肝疾患研究部 上級研究員 (20736219)
Project Period (FY) 2021-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2023: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2022: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2021: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywordsエピゲノム制御 / 栄養・代謝環境 / 酸化ストレス / 小胞体ストレス / 脂肪肝 / STC2 / LSD2 / 栄養環境 / 肝癌細胞 / エピゲノム / 脂質代謝 / NASH / 代謝リプログラミング / 肝発癌進展 / マイクロRNA / エピゲノム制御薬 / マルチオミクス解析
Outline of Research at the Start

原発性肝癌では、異常な栄養環境がエピゲノム制御を変化させ肝発癌進展に時空間的に関与する可能性が示唆される。
一方、マイクロRNA(miRNA)は内在性のRNAサイレンシング機構を担い遺伝子発現を制御するが、発現異常にはエピゲノム制御が関与している。
そこで異常な栄養環境がエピゲノム制御を介してmiRNAの発現を変化させ肝発癌増殖進展に寄与するかを、肝癌細胞を対象にmiRNA・遺伝子発現の網羅的解析を融合したマルチオミクス解析にて明らかにする。また異常栄養によるmiRNA発現変化を化合物ライブラリーにより再現できるかを検証すると共に、エピゲノム制御薬を用いた肝癌関連miRNAの発現制御を試みる。

Outline of Final Research Achievements

Based on our previous study that histone demethylase LSD2 is an epigenomic regulator of fat metabolism(doi: 10.1128 /MCB. 01404-14.), we investigated trophic factors involved in LSD2 expression. ChIP-seq analysis of HepG2 cells, together with analysis of signaling molecules, has revealed that oxidative stress in NASH liver regulates LSD2 expression. Next, we examined gene expression by nutritional environment in vivo. Ontology enrichment analysis on the liver tumors which were created in NASH liver of NOD-SCID mice, demonstrated that redox-regulated genes, ferotosis-related gene, and STC2 were up-regulated, while SREBP2 was down-regulated. In vitro study, oxidative stress stimuli up-regulated redox-regulated genes, whereas ER stress inducers increased STC2 gene expression and decreased SREBP2 expression. Furthermore, ER stress suppressed cell proliferation of STC2KO line, indicating that STC2 would suppress ER stress-induced cell death of liver cancer developed in NASH liver.

Academic Significance and Societal Importance of the Research Achievements

異常な栄養・代謝環境は、エピゲノム制御(DNAの塩基配列は変化せず、科学的な修飾により遺伝子発現が制御される)による遺伝子発現の変化を介して、疾患の発症に関連する。そこで我々は、脂肪肝に発生する酸化ストレスが、エピゲノム制御遺伝子の発現を変化させ、脂肪毒性による肝細胞障害を軽減することを示した。一方、マウス脂肪肝に作成した肝腫瘍では、酸化ストレスを軽減する遺伝子が発現すると共に、STC2遺伝子の発現により、小胞体ストレスによる肝癌細胞の細胞死を回避する事も明らかにした。このような細胞応答を明らかにすることは、栄養・代謝環境の改善による肝疾患進展や発癌の予防につながるものと期待される。

Report

(3 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2021 Research-status Report
  • Research Products

    (34 results)

All 2024 2023 2022 2021

All Journal Article (24 results) (of which Int'l Joint Research: 6 results,  Peer Reviewed: 24 results,  Open Access: 14 results) Presentation (10 results) (of which Int'l Joint Research: 5 results)

  • [Journal Article] Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence2024

    • Author(s)
      Qin XY, Shirakami Y, Honda M, Yeh SH, Numata K, Lai YY, Li CL, Wei F, Xu Y, Imai K, Takai K, Chuma M, Komatsu N, Furutani Y, Gailhouste L, Aikata H, Chayama K, Enomoto M, Tateishi R, Kawaguchi K, Yamashita T, Kaneko S, Nagaoka K, Tanaka M, Sasaki Y, Tanaka Y, Baba H, Miura K, Ochi S, Masaki T, et al
    • Journal Title

      International Journal of Cancer

      Volume: - Issue: 3 Pages: 582-594

    • DOI

      10.1002/ijc.34893

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents2024

    • Author(s)
      Suzuki Takanori、Matsuura Kentaro、Nagura Yoshihito、Kawamura Hayato、Fujiwara Kei、Ogawa Shintaro、Nagaoka Katsuya、Iio Etsuko、Watanabe Takehisa、Kataoka Hiromi、Tanaka Yasuhito
    • Journal Title

      Oncology

      Volume: - Issue: 7 Pages: 1-10

    • DOI

      10.1159/000536154

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA2024

    • Author(s)
      Watanabe Takehisa、Hayashi Sanae、Zhaoyu Yan、Inada Hiroki、Nagaoka Katsuya、Tateyama Masakuni、Tanaka Yasuhito
    • Journal Title

      Journal of Gastroenterology

      Volume: 59 Issue: 4 Pages: 315-328

    • DOI

      10.1007/s00535-023-02070-y

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase2024

    • Author(s)
      Nagaoka Katsuya、Bai Xuewei、Liu Dan、Cao Kevin、Mulla Joud、Ji Chengcheng、Chen Hongze、Nisar Muhammad Azhar、Bay Amalia、Mueller William、Hildebrand Grace、Gao Jin-Song、Lu Shaolei、Setoyama Hiroko、Tanaka Yasuhito、Wands Jack R.、Huang Chiung-Kuei
    • Journal Title

      Cancer Letters

      Volume: 580 Pages: 216493-216493

    • DOI

      10.1016/j.canlet.2023.216493

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinoma2023

    • Author(s)
      Yoshimaru Yoko、Nagaoka Katsuya、Tanaka Kentaro、Narahara Satoshi、Inada Hiroki、Kurano Sotaro、Tokunaga Takayuki、Iio Etsuko、Watanabe Takehisa、Setoyama Hiroko、Tateyama Masakuni、Yoshida Koji、Tsunoda Takuya、Nakamura Yusuke、Tanaka Motohiko、Sasaki Yutaka、Tanaka Yasuhito
    • Journal Title

      Hepatology Research

      Volume: - Issue: 5 Pages: 451-464

    • DOI

      10.1111/hepr.13995

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Clinical usefulness of inside stents in anastomotic biliary strictures after liver transplantation2023

    • Author(s)
      Kugiyama Naotaka、Hashigo Shunpei、Nagaoka Katsuya、Watanabe Takehisa、Ushijima Shinya、Uramoto Yukiko、Yoshinari Motohiro、Morinaga Jun、Gushima Ryosuke、Tateyama Masakuni、Tanaka Motohiko、Naoe Hideaki、Sugawara Yasuhiko、Hibi Taizo、Tanaka Yasuhito
    • Journal Title

      DEN Open

      Volume: 4 Issue: 1

    • DOI

      10.1002/deo2.305

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Serum inducible protein 10?kDa/C‐X‐C motif chemokine?10 levels predict regression of M2BPGi‐based liver fibrosis after hepatitis?C virus eradication by direct‐acting antiviral agents2023

    • Author(s)
      Nagura Yoshihito、Suzuki Takanori、Matsuura Kentaro、Ogawa Shintaro、Kawamura Hayato、Kuno Kayoko、Fujiwara Kei、Nojiri Shunsuke、Nagaoka Katsuya、Iio Etsuko、Watanabe Takehisa、Kataoka Hiromi、Tanaka Yasuhito
    • Journal Title

      Hepatology Research

      Volume: 54 Issue: 1 Pages: 32-42

    • DOI

      10.1111/hepr.13962

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Hepatitis B core-related antigen: a novel and promising surrogate biomarker to guide anti-HBV therapy.2023

    • Author(s)
      Inoue T, Watanabe T, Tanaka Y.
    • Journal Title

      Clin Mol Hepatol

      Volume: - Issue: 4 Pages: 851-868

    • DOI

      10.3350/cmh.2022.0434

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma2023

    • Author(s)
      Tokunaga Takayuki、Tateyama Masakuni、Kondo Yasuteru、Miuma Satoshi、Miyase Shiho、Tanaka Kentaro、Narahara Satoshi、Inada Hiroki、Kurano Sotaro、Yoshimaru Yoko、Nagaoka Katsuya、Watanabe Takehisa、Setoyama Hiroko、Fukubayashi Kotaro、Tanaka Motohiko、Tanaka Yasuhito
    • Journal Title

      Cancers

      Volume: 15 Issue: 5 Pages: 1568-1568

    • DOI

      10.3390/cancers15051568

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Exercise changes the intrahepatic immune cell profile and inhibits the progression of nonalcoholic steatohepatitis in a mouse model2023

    • Author(s)
      Tsutsui Yuriko、Mori Taizo、Yoshio Sachiyo、Sato Miku、Sakata Toshihiro、Yoshida Yuichi、Kawai Hironari、Yoshikawa Shiori、Yamazoe Taiji、Matsuda Michitaka、Kakazu Eiji、Osawa Yosuke、Oyama Chinatsu、Tamura-Nakano Miwa、Kawaguchi Takumi、Yoshizumi Tomoharu、Kanto Tatsuya
    • Journal Title

      Hepatology Communications

      Volume: 7 Issue: 10

    • DOI

      10.1097/hc9.0000000000000236

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Dried blood spot-based host genome analysis technique targeting pathological associations with hepatitis B: Development and clinical application in the Cambodian population.2023

    • Author(s)
      Setoyama H, Yamazoe T, Kanto T et al.
    • Journal Title

      Hepatol Res

      Volume: 12 Issue: 12 Pages: 1147-1155

    • DOI

      10.1111/hepr.13949

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Toll‐like receptor 7 agonist, GS‐986, is an immune‐stimulant inducing follicular helper T cells and expanding HBs antigen‐specific B cells <i>in vitro</i>2023

    • Author(s)
      Mori Taizo、Yoshio Sachiyo、Yoshikawa Shiori、Tsustui Yuriko、Sakata Toshihiro、Yoshida Yuichi、Sakamoto Yuzuru、Kawai Hironari、Osawa Yosuke、Yamazoe Taiji、Aoki Yoshihiko、Fletcher Simon P.、Kanto Tatsuya
    • Journal Title

      Liver International

      Volume: 43 Issue: 6 Pages: 1213-1224

    • DOI

      10.1111/liv.15568

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Serum osteopontin predicts the response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma2023

    • Author(s)
      Yamauchi Reika、Ito Takanori、Yoshio Sachiyo、Yamamoto Takafumi、Mizuno Kazuyuki、Ishigami Masatoshi、Kawashima Hiroki、Yasuda Satoshi、Shimose Shigeo、Iwamoto Hideki、Yamazoe Taiji、Mori Taizo、Kakazu Eiji、Kawaguchi Takumi、Toyoda Hidenori、Kanto Tatsuya
    • Journal Title

      Journal of Gastroenterology

      Volume: - Issue: 6 Pages: 565-574

    • DOI

      10.1007/s00535-023-01985-w

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Effects of sodium glucose cotransporter 2 inhibitors and pioglitazone on FIB‐4 index in metabolic‐associated fatty liver disease2023

    • Author(s)
      Mino Masaaki、Kakazu Eiji、Sano Akitoshi、Katsuyama Hisayuki、Hakoshima Mariko、Yanai Hidekatsu、Aoki Yoshihiko、Imamura Masatoshi、Yamazoe Taiji、Mori Taizo、Yoshio Sachiyo、Inoue Jun、Masamune Atsushi、Kanto Tatsuya
    • Journal Title

      Hepatology Research

      Volume: - Issue: 7 Pages: 618-628

    • DOI

      10.1111/hepr.13898

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Peripheral‐dominant liver fibrosis and tumor distribution in a mouse model of congestive hepatopathy2022

    • Author(s)
      Kawai Hironari、Osawa Yosuke、et al.
    • Journal Title

      Hepatology Research

      Volume: 53 Issue: 4 Pages: 370-376

    • DOI

      10.1111/hepr.13866

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Optimal management of lenvatinib therapy for patients with unresectable hepatocellular carcinoma by balancing the therapeutic effect with the relative dose intensity.2022

    • Author(s)
      Tokunaga T, Nagaoka K, Watanabe T, Tanaka M, Tanaka Y, et al.
    • Journal Title

      Hepatol Res

      Volume: 52 Issue: 1 Pages: 105-119

    • DOI

      10.1111/hepr.13720

    • Related Report
      2021 Research-status Report
    • Peer Reviewed
  • [Journal Article] Droplet digital PCR assay provides intrahepatic HBV?cccDNA quantification tool for clinical application2022

    • Author(s)
      Hayashi Sanae、Isogawa Masanori、Kawashima Keigo、Ito Kyoko、Chuaypen Natthaya、Morine Yuji、Shimada Mitsuo、Higashi-Kuwata Nobuyo、Watanabe Takehisa、Tangkijvanich Pisit、Mitsuya Hiroaki、Tanaka Yasuhito
    • Journal Title

      Scientific Reports

      Volume: 12 Issue: 1

    • DOI

      10.1038/s41598-022-05882-9

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma2021

    • Author(s)
      Narahara S, Watanabe T, Nagaoka K, Fujimoto N, Furuta Y, Tanaka K, Tokunaga T, Kawasaki T, Yoshimaru Y, Setoyama H, Oniki K, Saruwatari J, Tateyama M, Naoe H, Tanaka M, Tanaka Y, Sasaki Y.
    • Journal Title

      Hepatology Communications

      Volume: - Issue: 5 Pages: 1198-1212

    • DOI

      10.1002/hep4.1872

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Modified albumin?bilirubin grade to predict eligibility for second-line therapies at progression on sorafenib therapy in hepatocellular carcinoma patients2021

    • Author(s)
      Tokunaga Takayuki、Tanaka Motohiko、Tanaka Kentaro、Narahara Satoshi、Kawasaki Takeshi、Yoshimaru Yoko、Nagaoka Katsuya、Watanabe Takehisa、Tateyama Masakuni、Naoe Hideaki、Sasaki Yutaka、Tanaka Yasuhito
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 26 Issue: 5 Pages: 922-932

    • DOI

      10.1007/s10147-020-01835-2

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Murine neonatal ketogenesis preserves mitochondrial energetics by preventing protein hyperacetylation2021

    • Author(s)
      Arima Yuichiro、Nakagawa Yoshiko、Takeo Toru、Ishida Toshifumi、Yamada Toshihiro、et al.
    • Journal Title

      Nature Metabolism

      Volume: 3 Issue: 2 Pages: 196-210

    • DOI

      10.1038/s42255-021-00342-6

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Ten‐Eleven Translocation 1 Promotes Malignant Progression of Cholangiocarcinoma With Wild‐Type Isocitrate Dehydrogenase 12021

    • Author(s)
      Bai Xuewei、Zhang Hongyu、Zhou Yamei、Nagaoka Katsuya、Meng Jialin、Ji Chengcheng、Liu Dan、Dong Xianghui、Cao Kevin、Mulla Joud、Cheng Zhixiang、Mueller William、Bay Amalia、Hildebrand Grace、Lu Shaolei、Wallace Joselynn、Wands Jack R.、Sun Bei、Huang Chiung‐Kuei
    • Journal Title

      Hepatology

      Volume: 73 Issue: 5 Pages: 1747-1763

    • DOI

      10.1002/hep.31486

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Sphingosine‐1‐phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy2021

    • Author(s)
      Kawai H, Osawa Y, Matsuda M, Tsunoda T, Yanagida K, Hishikawa D, Okawara M, Sakamoto Y, Shimagaki T, Tsutsui Y, Yoshida Y, Yoshikawa S, Hashi K, Doi H, Mori T, Yamazoe T, Yoshio S, Sugiyama M, Okuzaki D, Komatsu H, Inui A, Tamura-Nakano M, Oyama C, Shindou H, Kusano H, Kage M, Ikegami T, Yanaga K, Kanto T
    • Journal Title

      Hepatology

      Volume: - Issue: 1 Pages: 112-125

    • DOI

      10.1002/hep.32256

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Cluster of Differentiation 44 Promotes Liver Fibrosis and Serves as a Biomarker in Congestive Hepatopathy2021

    • Author(s)
      Osawa Y, Kawai H, Yamazoe T, Kanto T, et al.
    • Journal Title

      Hepatology Communications

      Volume: 5 Issue: 8 Pages: 1437-1447

    • DOI

      10.1002/hep4.1721

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Calcium signaling induces a partial EMT2021

    • Author(s)
      NorgardJason RJ, Yamazoe T, Stranger BZ, et al.
    • Journal Title

      EMBO Reports

      Volume: - Issue: 9

    • DOI

      10.15252/embr.202051872

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] TET1-mediated 5-hydroxymethylcytosine is involved in hepatocyte apoptosis in alcoholic liver disease progression.2023

    • Author(s)
      Nagaoka K, Huang C K., Tanaka Y.
    • Organizer
      JSH International Liver Conference
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research
  • [Presentation] A Possible diagnostic marker of mitochondrial dysfunction, AREG, is associated with tumor size in hepatocellular carcinoma.2023

    • Author(s)
      Nagaoka K, Watanabe T, Tanaka Y, et al.
    • Organizer
      APASL Single Topic Conference
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research
  • [Presentation] INTERFERON-RELATED GENE EXPRESSION CHANGES MEDIATED BY ALPHAFETOPROTEIN IN PATIENTS WHO DEVELOPED HEPATOCELLULAR CARCINOMA AFTER HEPATITIS C VIRUS ERADICATION2023

    • Author(s)
      Nagaoka K, Watanabe T, Tanaka Y, et al.
    • Organizer
      American Association for the Study of Liver Disease, Liver meeting
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research
  • [Presentation] ミトコンドリア機能不全がもたらすNAFLD肝組織におけるアンフィレグリン発現増加2023

    • Author(s)
      長岡克弥、渡邊丈久、田中靖人
    • Organizer
      第109回日本消化器病学会総会 シンポジウム13
    • Related Report
      2023 Annual Research Report
  • [Presentation] 転写因子・エピゲノム統合解析を用いた肝細胞癌ミトコンドリア機能不全の診断マーカーの同定2023

    • Author(s)
      長岡克弥、渡邊丈久、田中靖人
    • Organizer
      第59回日本肝臓学会総会パネルディスカッション4
    • Related Report
      2023 Annual Research Report
  • [Presentation] Elevated 2-oxoglutarate antagonizes chemotherapeutic effects in cholangiocarcinoma by targeting DNA damage response signaling pathways.2021

    • Author(s)
      Nagaoka K, Chengcheng Ji, Wands JR, et al.
    • Organizer
      The 72nd Annual Meeting of the American Association for the Study of Liver Diseases
    • Related Report
      2021 Research-status Report
    • Int'l Joint Research
  • [Presentation] 肝内胆管癌におけるAspartateβ-hydroxylase阻害剤とDNA合成阻害剤による相乗的なDNA損傷と抗腫瘍効果の検討2021

    • Author(s)
      長岡克弥、HuangChiung-Kuei、田中靖人
    • Organizer
      第57回日本肝臓学会総会
    • Related Report
      2021 Research-status Report
  • [Presentation] ヒストン修飾酵素LSD2による肝脂質代謝制御と栄養環境対応性の発現変化~NAFLDの病態解明を目指して~2021

    • Author(s)
      長岡克弥、渡邊丈久、楢原哲史、田中健太郎、徳永尭之、川崎剛、吉丸洋子、瀬戸山博子、立山雅邦、田中基彦、佐々木裕、田中靖人
    • Organizer
      第25回日本肝臓学会大会
    • Related Report
      2021 Research-status Report
  • [Presentation] 肝細胞癌に対するソラフェニブ・レンバチニブの薬剤選択に有用な血清バイオマーカーの解析2021

    • Author(s)
      楢原哲史、渡邊丈久、田中靖人
    • Organizer
      第57回 日本肝臓学会
    • Related Report
      2021 Research-status Report
  • [Presentation] Novel serum biomarkers useful for drug selection of sorafenib and lenvatinib for hepatocellular carcinoma2021

    • Author(s)
      Narahara S, Watanabe T, Tanaka Y, et al.,
    • Organizer
      The 72nd Annual Meeting of the American Association for the Study of Liver Diseases
    • Related Report
      2021 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2021-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi